Influence of Patient and Treatment Factors on Adherence to Adjuvant Endocrine Therapy in Breast Cancer
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
PURPOSE/OBJECTIVES: To comprehensively assess the patient and illness or treatment factors that may predict nonadherence to adjuvant endocrine therapy and to explore whether an interaction occurs between these factors in women with breast cancer. DESIGN: Repeated-measures design. SETTING: The Outpatient Services of the Women's Cancer Program at the University of Pittsburgh Cancer Institute and participants' homes. SAMPLE: 91 women with early-stage breast cancer who received endocrine therapy. METHODS: Adherence was assessed continuously for the first 18 months of endocrine therapy. Patient and illness or treatment factors were assessed at four time points (Time 1 to Time 4). Time 1 (baseline) was within two weeks prior to the initiation of endocrine therapy. Times 2-4 occurred at six-month intervals, as many as 18 months after Time 1. MAIN RESEARCH VARIABLES: Adherence, patient factors, and illness or treatment factors. FINDINGS: Adherence to endocrine therapy declined significantly during the first 18 months of treatment in women with breast cancer. The presence of negative mood and symptoms before starting treatment predicted nonadherence to endocrine therapy over time. Perceptions of financial hardship, symptoms, disease stage, and more complex medication regimens intensified the effect of negative mood on adherence over time. CONCLUSIONS: Women with breast cancer may be at risk for nonadherence to prescribed endocrine therapy if they experience depression or anxiety and symptoms prior to initiating therapy. IMPLICATIONS FOR NURSING: Oncology nurses should be alert to women with breast cancer who are depressed or anxious or who are experiencing symptoms. Management of negative mood and symptoms may result in better adherence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated anxiety predicts nonadherence to recommended therapies, [23][24][25] higher use and costs of medical care, [26][27][28] and possibly cancer recurrence.29”
From Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update (2023) · cites this paper as [24]
Citations
Cites
Beck, A. T., Steer, R. A., & Brown, G. (2011) · PsycTESTS Dataset · doi:10.1037/t00742-000 · Cited by 7,535
Horne, R., Weinman, J., & Hankins, M. (1999) · Psychology & Health · doi:10.1080/08870449908407311 · Cited by 2,372 · cited 1×
“Perceived treatment efficacy was evaluated with the 10-item Beliefs About Medicines Questionnaire (BMQ)–specific subscale (Horne, Weinman, & Hankins, 1999).”
Measuring the Functional Components of Social Support
Cohen, S., Mermelstein, R., Kamarck, T., & Hoberman, H. M. (1985) · Social Support: Theory, Research and Applications · doi:10.1007/978-94-009-5115-0_5 · Cited by 2,296 · cited 2×
“Test-retest correlations were 0.87 for two days, 0.7 for six weeks, and 0.74 for six months (Cohen et al., 1985).”
InfluentialSelf-citationPatient adherence to treatment: three decades of research. A comprehensive review
Vermeire, E., Hearnshaw, H., Van Royen, P., & Denekens, J. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00363.x · Cited by 1,833 · cited 1×
“Although the potential negative impact of financial hardship related to disease management on nonadherence has been explored (Griffith, 1990; Morris & Schulz, 1992; Vermeire, Hearnshaw, Van Royen, & Denekens, 2001), little is known about the role of financial hardship on”
Tamoxifen in the Treatment of Breast Cancer
Osborne, C. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811263392207 · Cited by 1,320
Mor, V., Laliberte, L., Morris, J. N., & Wiemann, M. (1984) · Cancer · doi:10.1002/1097-0142(19840501)53:9<2002::aid-cncr2820530933>3.0.co;2-w · Cited by 1,067 · cited 1×
“Although the potential negative impact of financial hardship related to disease management on nonadherence has been explored (Griffith, 1990; Morris & Schulz, 1992; Vermeire, Hearnshaw, Van Royen, & Denekens, 2001), little is known about the role of financial hardship on”
Neuropsychological assessment.
Garb, H. N. (2004) · Studying the clinician: Judgment research and psychological assessment. · doi:10.1037/10299-006 · Cited by 876
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676
Leukemia, E. I. C. M. (2013) · Blood · doi:10.1182/blood-2013-03-490003 · Cited by 592
Konecny, G., Pauletti, G., Pegram, M., Untch, M., Dandekar, S., Aguilar, Z., Wilson, C., Rong, H.-M., Bauerfeind, I., Felber, M., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.142 · Cited by 588 · cited 1×
“About 80% of breast cancers express hormone receptors (Konecny et al., 2003).”
Research works printed but not linked: 3
- D. McNair, 1992, EdITS manual for the profile of mood states
- H. Nelson, 1981, National adult reading test (NART) manual
- O. Spreen, 1998, A compendium of neuropsychogical test: Administration, norms, and commentary
Cited by
Items 101–131 of 131
Resistance to Resilience: Understanding Post-surgical Hormone Therapy in Breast Cancer Care
Kumar, T., Dutta, R. R., Thakre, S., Singh, A., Velagala, V. R., & Shinde, R. K. (2023) · Cureus · doi:10.7759/cureus.47869 · Cited by 6
“Some of the most common side effects are joint pain/osteoporosis, depressive episodes, hot flashes, difficulty sleeping, fatigue, anxiousness, and weight-related issues [15-21].”
BackgroundCéspedes, P., Martínez‐Arnau, F. M., Torregrosa, M. D., Cauli, O., & Buigues, C. (2025) · Clinics and Practice · doi:10.3390/clinpract15030041 · Cited by 1
Evaluation of illness perception and treatment adherence in patients taking oral chemotherapy
Bicav, B., & Kutlutürkan, S. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09961-1 · Cited by 2
“Research indicates that patients with more negative illness perceptions, such as viewing the illness as severe, uncontrollable, or poorly understood, tend to demonstrate lower adherence to medical recommendations and are less likely to manage symptoms effectively [9–11].”
Ernst, S. W., Knight, R., Royle, J., & Stephenson, L. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820493-1.00015-5 · Cited by 1
Shen, C., Li, N., Zhou, S., Stahl, K. A., Dodge, D. G., & Zhao, H. (2022) · Cancer Medicine · doi:10.1002/cam4.5488 · Cited by 1
Schutzmeier, M., Brandstetter, L., Stangl, S., Ahnert, J., Grau, A., Gerken, L., Klingshirn, H., Reuschenbach, B., Skazel, T., Kippnich, M., et al. (2024) · BMC Health Services Research · doi:10.1186/s12913-024-10583-2 · Cited by 1
Lee, K. T., Geiss, C., Fulton, H. J., Charles, D., Gonzalez, B. D., Jim, H., Henry, N. L., Hershman, D. L., Tworoger, S. S., Bradbury, A. R., et al. (2025) · Clinical Breast Cancer · doi:10.1016/j.clbc.2025.06.010 · Cited by 1
Washburn, D., & Thompson, K. (2020) · Clinical journal of oncology nursing · doi:10.1188/20.cjon.e13-e20 · Cited by 1
Retiro de medicamentos antineoplásicos en un hospital nacional en Costa Rica
Solórzano, C. G., Salas, A. L., Cartín-Ruiz, S., & Santamaría‐Ulloa, C. (2020) · Revista de la OFIL · doi:10.4321/s1699-714x20200001000012 · Cited by 1
Andersen, B. L., Conley, C. C., & Blevins, T. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818697-8.00077-7 · Cited by 1
Patient Centric Healthcare – What's Stopping Us?
Royle, J., & Jones, R. (2023) · Wiley eBooks · doi:10.1002/9781119615583.ch1 · Cited by 2
Pinheiro, L. C. (2017) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/cyj6-pt59
Understanding adherence to adjuvant endocrine therapy in breast cancer survivors
Lambert, L. K. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0380494 · Cited by 1
Depressive and Anxiety Symptoms and Disorders
Dorfman, C. S., Arrato, N. A., Arthur, S. S., & Andersen, B. L. (2021) · Springer eBooks · doi:10.1007/978-3-030-75377-1_12
Herausforderung Adhärenz bei der oralen Behandlung der CLL
(2022) · CNE Pflegemanagement · doi:10.1055/a-1775-2821
Hormonioterapia sob o olhar de mulheres com câncer de mama
Pinheiro, M. C. M. V. (2020) · doi:10.47749/t/unicamp.2020.1149220
Zhukovsky, D. S. (2015) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2015.10.001
Molina‐Garrido, M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732811904.793553825
Shinn, E. H., Busch, B. E., Jasemi, N., Lyman, C. A., Toole, J. T., Richman, S., Symmans, W. F., Chávez‐MacGregor, M., Peterson, S. K., & Broderick, G. (2022) · Frontiers in Psychology · doi:10.3389/fpsyg.2022.856813 · Cited by 1
“Within the body of ET adherence literature that included a priori measurement of psychosocial factors, moderate but inconsistent effects have been found for depression (Bender et al., 2014), anxiety (Stanton et al.”
BackgroundTerapia oral antineoplásica: análise da adesão e fatores associados
Bernardes, M. P. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.7.2021.tde-12012022-171631
Myrzaliyev, N. K., Olzhayev, S. T., Маншарипова, А. Т., Краснов, Г. С., Adzhibaev, B., Гехаев, А. У., Шостак, Е. Е., & Lenkin, S. G. (2025) · Успехи геронтологии · doi:10.34922/ae.2025.38.1.002
Zhao, J., Abujaradeh, H., Mazanec, S. R., Bender, C. M., Sereika, S. M., & Rosenzweig, M. Q. (2025) · Cancer Nursing · doi:10.1097/ncc.0000000000001527 · Cited by 1
Self-citationBanys-Paluchowski, M. J., Lüftner, D., Korfel, A., Chouaki, N., Sanderson, I., Barlow, S. G., Rider, A., Liepa, A. M., & Jackisch, C. (2025) · Breast Care · doi:10.1159/000547748
“Many factors can impact adherence to ET in patients with breast cancer, including psychosocial factors, and illness-and treatment-related factors [14–16]; improving patient satisfaction with how they are coping with their disease could help improve treatment adherence [13, 17].”
Schutzmeier, M., Brandstetter, L., Stangl, S., Ahnert, J., Grau, A., Gerken, L., Klingshirn, H., Reuschenbach, B., Skazel, T., Kippnich, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26674796
Schutzmeier, M., Brandstetter, L., Stangl, S., Ahnert, J., Grau, A., Gerken, L., Klingshirn, H., Reuschenbach, B., Skazel, T., Kippnich, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25116044
Schutzmeier, M., Brandstetter, L., Stangl, S., Ahnert, J., Grau, A., Gerken, L., Klingshirn, H., Reuschenbach, B., Skazel, T., Kippnich, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25116234
Queiroz, A. P. M. O., de Aguiar, V. S., Borges, L. M., & dos Santos, J. R. B. (2026) · Psicologia e Saúde em Debate · doi:10.22289/2446-922x.v12a1a75
Zelaya, M. G., Borjigin, M., Lahiji, R., Fung, G., Bausum, A., Melikian, M., Catic, A., Mumford, S., Slomik, H., Nguyen, J., et al. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-11098-8
“Similar psychological distress patterns have been associated with reduced adherence to medical therapies in prior meta-analyses [28–30].”
Huang, T. Q., McClellan, S. R., Brooks, G. A., Trombley, M. J., Kummet, C. M., & Keating, N. L. (2026) · JCO Oncology Practice · doi:10.1200/op-26-00383
Lin, K., & Lin, K. (2026) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552261487600
Metadata
- Authors
- Bender, C. M., Gentry, A. L., Brufsky, A. M., Casillo, F. E., Cohen, S. M., Dailey, M. M., Donovan, H. S., Dunbar-Jacob, J., Jankowitz, R. C., Rosenzweig, M. Q., Sherwood, P. R., & Sereika, S. M.
- Affiliations
- UPMC Hillman Cancer Center (US)
- University of Pittsburgh (US)
- ORCID
- Venue
- Oncology Nursing Forum
- Publisher
- Oncology Nursing Society (ONS)
- Published
- 2014-04-25
- Volume
- 41
- Issue
- 3
- Pages
- 274-285
- ISSN
- 0190-535X (ISSN-L)
- 1538-0688
- PMC
- PMC4090095
- OpenAlex
- W1992203573
- Cited by
- 131
- References
- 50
- Citations by year
- 2026: 5 · 2025: 9 · 2024: 7 · 2023: 7 · 2022: 16 · 2021: 15 · 2020: 17 · 2019: 11 · 2018: 12 · 2017: 15 · 2016: 8 · 2015: 8 · 2014: 1
- FWCI
- 10.95
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Oncology nursing forum (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (UL1TR000005)
- National Cancer Institute (R01CA107408)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- breast cancer, adjuvant endocrine therapy, medication adherence, non-compliance, negative mood, depression, anxiety, financial hardship, symptom burden, disease stage, medication regimen complexity, predictors of non-adherence
- MeSH terms
- Adolescent, Adult, Affect, Aged, Breast Neoplasms, Depression, Female, Follow-Up Studies, Forecasting, Humans, Middle Aged, Patient Compliance, Pennsylvania, Socioeconomic Factors, Tamoxifen, Time Factors, Comorbidity, Chemotherapy, Adjuvant, Antineoplastic Agents, Hormonal, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.